Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.34M Sell
6,452
-375
-5% -$128K 0.27% 71
2026
Q1
$2.4M Buy
6,827
+4,895
+253% +$1.75M 0.31% 69
2025
Q4
$632K Hold
1,932
0.09% 103
2025
Q3
$545K Buy
1,932
+200
+12% +$58K 0.08% 109
2025
Q2
$484K Sell
1,732
-190
-10% -$53.8K 0.07% 109
2025
Q1
$599K Buy
1,922
+69
+4% +$20.4K 0.1% 104
2024
Q4
$483K Sell
1,853
-20
-1% -$5.93K 0.08% 108
2024
Q3
$603K Sell
1,873
-37
-2% -$12.1K 0.1% 105
2024
Q2
$597K Sell
1,910
-240
-11% -$70.5K 0.1% 100
2024
Q1
$611K Buy
2,150
+190
+10% +$55.6K 0.11% 101
2023
Q4
$565K Hold
1,960
0.11% 102
2023
Q3
$527K Buy
1,960
+220
+13% +$54.9K 0.11% 101
2023
Q2
$386K Hold
1,740
0.07% 105
2023
Q1
$421K Buy
1,740
+290
+20% +$71.2K 0.09% 103
2022
Q4
$381K Hold
1,450
0.08% 105
2022
Q3
$326K Buy
1,450
+240
+20% +$58.2K 0.08% 105
2022
Q2
$294K Hold
1,210
0.06% 109
2022
Q1
$292K Buy
+1,210
New +$278K 0.06% 110
2015
Q3
Sell
-1,355
Closed -$208K 84
2015
Q2
$208K Hold
1,355
0.08% 82
2015
Q1
$217K Buy
+1,355
New +$213K 0.09% 83

Other funds holding AMGN

Culbertson A N & Co's AMGN Position: Q2 2026 in Review

Culbertson A N & Co reduced its Amgen (AMGN) stake by 5.5% in Q2 2026, selling an estimated $128K and leaving 6,452 shares worth $2.34M. The position accounts for 0.27% of the portfolio, ranked #71.

Culbertson A N & Co first reported a position in AMGN in Q1 2015 and has held it in 20 quarters since. The position peaked at $2.4M in Q1 2026. 1,372 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Culbertson A N & Co held 6,452 shares of Amgen worth $2.34M as of Q2 2026.
  • Culbertson A N & Co sold 375 Amgen shares in Q2 2026, an estimated $128K.
  • Amgen made up 0.27% of Culbertson A N & Co's portfolio in Q2 2026, its #71 holding.
  • Culbertson A N & Co first reported a position in Amgen in Q1 2015 and has held it in 20 quarters since.
  • Culbertson A N & Co's Amgen position peaked at $2.4M in Q1 2026.
  • 1,372 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Culbertson A N & Co's 13F filing for Q2 2026, filed 29 Jul 2026.